Delivery Order SPE2DB22D3501-SPE2DB25FWN86
- Not listed
- The Defense Logistics Agency awarded a $10,100.87 delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Humulin R 500 unit/mL KwikPen 3mL insulin pens. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 18, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting the company's demonstrated capability to compete in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Humulin R 500 Unit/ML KwikPen 3ML insulin pens, valued at $20,724.74. This non-set-aside, firm fixed-price delivery order is scheduled for completion by August 5, 2025, and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. The contract represents a continuation of pharmaceutical procurement through DLA's medical supply chain to support federal...
- The Defense Logistics Agency awarded a $3,484.71 delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for Humulin R 500 Unit/mL KwikPen 3mL insulin pens. This is a firm fixed-price delivery order with an ultimate completion date of August 5, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract was awarded without a set-aside designation through open competition. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $26,828.48 to AmerisourceBergen Drug Corp for Humulin R 500 Unit/ML KwikPen 3ML insulin pens. This competitively awarded, firm fixed-price delivery order is scheduled for completion by July 31, 2025, and represents a single transaction under AmerisourceBergen's existing contract vehicle with DLA. The pharmaceutical product will be delivered to the company's distribution center in Conshohocken, Pennsylvania. As a non-set-aside...
- The Defense Logistics Agency awarded a $3,252.20 delivery order to AmerisourceBergen Drug Corp for Humulin R 500 Unit/mL KwikPen 3mL insulin pens on July 31, 2025, with an ultimate completion date of August 1, 2025. This firm fixed-price, competitively awarded contract involves no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Humulin R 500 Unit/mL KwikPen 3mL insulin pens, valued at $3,097.52. This is a firm fixed-price delivery order with an ultimate completion date of August 4, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Humulin R 500 Unit/mL KwikPen 3mL insulin pens, valued at $6,578.04. This competitively awarded, firm fixed-price delivery order is set to be completed by August 14, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a discrete pharmaceutical procurement under AmerisourceBergen's broader federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Humulin R 500 Unit/ML KwikPen 3ML insulin pens, valued at $18,663.84 under a firm fixed-price contract type. This non-set-aside award represents a critical pharmaceutical procurement to support federal healthcare operations, with an ultimate completion date of August 5, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major...
- The Defense Logistics Agency awarded a $16,119.96 delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Humulin R 500 Unit/mL KwikPen 3mL insulin pens. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 8, 2025. AmerisourceBergen will perform this work from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Humulin R 500 Unit/ML KwikPen 3ML insulin products, with a ceiling value of $2,710.33. This firm fixed-price delivery order, which is not set-aside and was competitively awarded, is expected to be completed by August 12, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company is headquartered and...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FWN86Delivery Order
The Defense Logistics Agency (DLA) awarded a $2,729.66 delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Humulin R 500 Unit/mL KwikPen 3mL insulin pens. The contract utilizes firm fixed-price pricing with no set-aside designation, indicating competitive award. Performance is scheduled to conclude by July 24, 2025, with fulfillment occurring at the vendor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical supplier, fulfills this pharmaceutical delivery through its comprehensive global pharmaceutical support vehicle with DLA. The parent IDC enables the contractor to supply an extensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, vaccines, and medical commodities across multiple therapeutic domains. This delivery order for insulin represents one of numerous competitively awarded transactions under the prime vendor agreement, serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 7/23/25 |